86 related articles for article (PubMed ID: 10613026)
1. [The developing profile of cerebral ischemia].
Martí-Vilalta JL; Martí-Fábregas J
Neurologia; 1999; 14 Suppl 4():2-10. PubMed ID: 10613026
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
Thiyagarajan M; Kaul CL; Sharma SS
Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
[TBL] [Abstract][Full Text] [Related]
4. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
[TBL] [Abstract][Full Text] [Related]
5. Opioids modulate post-ischemic progression in a rat model of stroke.
Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
[TBL] [Abstract][Full Text] [Related]
6. [Consensus review. Pharmacological neuroprotection in cerebral ischemia: is it still a therapeutic option?].
Castillo J; Alvarez-Sabin J; Dávalos A; Diez-Tejedor E; Lizasoain I; Martínez-Vila E; Vivancos J; Zarranz JJ
Neurologia; 2003 Sep; 18(7):368-84. PubMed ID: 14505245
[TBL] [Abstract][Full Text] [Related]
7. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils.
Lee H; Bae JH; Lee SR
J Neurosci Res; 2004 Sep; 77(6):892-900. PubMed ID: 15334607
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Hadjiev D
Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
Kaundal RK; Shah KK; Sharma SS
Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310
[TBL] [Abstract][Full Text] [Related]
13. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].
Feng XY; Liang J; Yin XD; Han X; Dong Q; Lü CZ
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):952-7. PubMed ID: 12899795
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin preconditioning induces protective effects against focal cerebral ischemia in rats.
Ping A; Chun ZX; Xue XY
Brain Res; 2005 Oct; 1059(2):105-12. PubMed ID: 16182259
[TBL] [Abstract][Full Text] [Related]
15. [Establishment and evaluation of reproduction of middle cerebral artery occlusion to produce cerebral ischemia with autologous blood clot and nylon thread in rat].
Li JS; Liu JX; Yu HB; Wang D
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May; 18(5):272-4. PubMed ID: 16700989
[TBL] [Abstract][Full Text] [Related]
16. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
[TBL] [Abstract][Full Text] [Related]
17. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
18. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia.
Rahman RM; Nair SM; Helps SC; Shaw OM; Sims NR; Rosengren RJ; Appleton I
Neurosci Lett; 2005 Jul; 382(3):227-30. PubMed ID: 15925095
[TBL] [Abstract][Full Text] [Related]
20. Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats.
Tsubokawa T; Yamaguchi-Okada M; Calvert JW; Solaroglu I; Shimamura N; Yata K; Zhang JH
J Neurosci Res; 2006 Sep; 84(4):832-40. PubMed ID: 16802320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
